Baxter Healthcare will pay Samsung Biologics an extra $208 million to manufacture certain drug products until the end of 2034 ...
SPACs might never fully go away if the ambitions of three new healthcare-focused shops have any sway. As initial public ...
The FDA ap­proved Ab­b­Vie’s Skyrizi to treat mod­er­ate to se­vere ul­cer­a­tive col­i­tis, adding an­oth­er in­di­ca­tion ...
The In­ter­na­tion­al So­ci­ety for Cell and Gene Ther­a­py is push­ing back against a Utah law that al­lows health­care ...
A Third Rock Ven­tures-in­cu­bat­ed start­up called Marea Ther­a­peu­tics de­buted Tues­day with $190 mil­lion to ad­vance a ...
The FDA is no longer requiring the reporting of two common — and sometimes serious — side effects for a handful of CAR-T ...
The Fed­er­al Trade Com­mis­sion on Tues­day of­fered up sup­port for a pro­posed rule from the US Patent and Trade­mark ...
Teva and the US government are in talks to settle a lawsuit against the company alleging a kickback scheme for its blockbuster multiple sclerosis drug Copaxone. In court documents filed over the ...
Intra-Cellular Therapies has nailed a second Phase 3 study testing its antipsychotic medication Caplyta as an adjunctive ...
Taysha Gene Therapies’ treatment candidate for Rett syndrome has shown hints of efficacy in a handful of adult and pediatric ...
The FDA put three clin­i­cal stud­ies of Zen­tal­is’ WEE1 in­hibitor on par­tial hold fol­low­ing two pa­tient deaths like­ly ...
Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.